Cargando…

First Morning Pregnanetriol and 17-Hydroxyprogesterone Correlated Significantly in 21-Hydroxylase Deficiency

BACKGROUND: Biochemically monitoring 21-hydroxylase deficiency (21-OHD) is challenging. Serum/blood 17-hydroxyprogesterone (17OHP) measurements are normally used for this purpose. Urinary pregnanetriol (PT), a urinary metabolite of 17OHP, may also be used. Based on auxological data, we previously re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Itonaga, Tomoyo, Izawa, Masako, Hamajima, Takashi, Hasegawa, Yukihiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8820395/ https://www.ncbi.nlm.nih.gov/pubmed/35140686 http://dx.doi.org/10.3389/fendo.2021.808254

Ejemplares similares

Monitoring treatment in pediatric patients with 21-hydroxylase deficiency
por: Itonaga, Tomoyo, et al.
Publicado: (2023)

The Range of 2.2–3.3 mg/gCr of Pregnanetriol in the First Morning Urine Sample as an Index of Optimal Control in CYP21 Deficiency
por: Izawa, Masako, et al.
Publicado: (2008)

Pregnanetriol in the Range of 1.2–2.1 mg/m(2)/day as an Index of Optimal Control in CYP21A2 Deficiency
por: Izawa, Masako, et al.
Publicado: (2007)

Therapeutic needs from early childhood in four patients with 21-hydroxylase deficiency harboring the P30L mutation on one allele
por: Itonaga, Tomoyo, et al.
Publicado: (2021)

High-Dose Hook Effect in 17-Hydroxyprogesterone Assay in a Patient with 21-Hydroxylase Deficiency
por: Parlak, Mesut, et al.
Publicado: (2015)

Measurement of 17-Hydroxyprogesterone by LCMSMS Improves Newborn Screening for CAH Due to 21-Hydroxylase Deficiency in New Zealand
por: de Hora, Mark R., et al.
Publicado: (2020)

Genotype-phenotype correlation in patients with 21-hydroxylase deficiency
por: Tang, Peng, et al.
Publicado: (2023)

New insights on hyperglycemia in 17-hydroxylase/17,20-lyase deficiency
por: Xu, Lingling, et al.
Publicado: (2022)

The Complexities in Genotyping of Congenital Adrenal Hyperplasia: 21-Hydroxylase Deficiency
por: Pignatelli, Duarte, et al.
Publicado: (2019)

The prevalence and genotype of 21-hydroxylase deficiency in the Croatian Romani population
por: Dumic, Katja K., et al.
Publicado: (2023)

Corrigendum: The Complexities in Genotyping of Congenital Adrenal Hyperplasia: 21-Hydroxylase Deficiency
por: Pignatelli, Duarte, et al.
Publicado: (2020)

Molecular Diagnosis of Steroid 21-Hydroxylase Deficiency: A Practical Approach
por: Arriba, María, et al.
Publicado: (2022)

Pubertal induction in Turner syndrome without gonadal function: A possibility of earlier, lower-dose estrogen therapy
por: Hasegawa, Yukihiro, et al.
Publicado: (2023)

Quality of Life in Men With Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
por: Verhees, Myrthe J. M., et al.
Publicado: (2021)

Dexamethasone application for in vitro fertilisation in non-classic 17-hydroxylase/17,20-lyase-deficient women
por: Yang, Xiu-Li, et al.
Publicado: (2022)

Characteristics of In2G Variant in Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
por: Kocova, Mirjana, et al.
Publicado: (2022)

Obesity and Cardiometabolic Risk Factors in Children and Young Adults With Non-classical 21-Hydroxylase Deficiency
por: de Vries, Liat, et al.
Publicado: (2019)

Model-Informed Target Morning 17α-Hydroxyprogesterone Concentrations in Dried Blood Spots for Pediatric Congenital Adrenal Hyperplasia Patients
por: Stachanow, Viktoria, et al.
Publicado: (2023)

Relationships of Basal Level of Serum 17-Hydroxyprogesterone with that of Serum Androstenedione and Their Stimulated Responses to a Low Dose of ACTH in Young Adult Patients with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
por: Kang, Min Jae, et al.
Publicado: (2011)

Clinical characteristics and molecular etiology of partial 17α-hydroxylase deficiency diagnosed in 46,XX patients
por: Zhang, Duoduo, et al.
Publicado: (2022)

SUN-037 Discordant Serum 17-hydroxyprogesterone and Androstenedione in the Management of Congenital Adrenal Hyperplasia: Are 11-oxygenated Androgens Useful?
por: Jha, Smita, et al.
Publicado: (2020)

Long-Term Health Outcomes of Korean Adults With Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
por: Lim, Seung Gyun, et al.
Publicado: (2021)

The underlying cause of the simple virilizing phenotype in patients with 21-hydroxylase deficiency harboring P31L variant
por: Zhao, Zhiyuan, et al.
Publicado: (2023)

Ovarian gonadoblastoma with dysgerminoma in a girl with 46,XX karyotype 17a-hydroxylase/17, 20-lyase deficiency: A case report and literature review
por: Yin, Min, et al.
Publicado: (2022)

Corticosteroid Biosynthesis Revisited: No Direct Hydroxylation of Pregnenolone by Steroid 21-Hydroxylase
por: Loke, Steffen, et al.
Publicado: (2021)

An Asian case of combined 17α-hydroxylase/17,20-lyase deficiency due to homozygous p.R96Q mutation: A case report and review of the literature
por: Liao, Qian, et al.
Publicado: (2022)

Co-production of 11α-hydroxyprogesterone and ethanol using recombinant yeast expressing fungal steroid hydroxylases
por: Hull, Claire M., et al.
Publicado: (2017)

A Case of a Preterm Infant with 21-Hydroxylase Deficiency: Implications of the Biochemical Diagnosis with Urinary Pregnanetriolone by Gas Chromatography/Mass Spectrometry in Selected Ion Monitoring (GCMS-SIM)
por: Hamajima, Takashi, et al.
Publicado: (2004)

Genetic and clinical characteristics including occurrence of testicular adrenal rest tumors in Slovak and Slovenian patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
por: Saho, Robert, et al.
Publicado: (2023)

SAT-277 Re-Evaluation of the 17-Hydroxyprogesterone (17-OHP) Screening Threshold for Diagnosing Nonclassic Congenital Adrenal Hyperplasia (NCCAH) in the Era of Liquid Chromatography Tandem-Mass Spectrometry (LC-MS/MS)
por: Chesover, Alexander, et al.
Publicado: (2019)

Reproductive endocrine characteristics and in vitro fertilization treatment of female patients with partial 17α-hydroxylase deficiency: Two pedigree investigations and a literature review
por: Jiang, Shutian, et al.
Publicado: (2022)

SUN-LB11 What Is the Value of Clinical Suspicion in Neonatal Screening for Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency (CAH 21OHD)?
por: Fernández, María Sanz, et al.
Publicado: (2020)

SAT358 Race And Ethnicity Of Women With 21-hydroxylase Deficient Non-classic Adrenal Hyperplasia (NCAH) Compared With PCOS
por: Pace, Lauren Arielle, et al.
Publicado: (2023)

The Influence of Prior Obstetrical History on Current 17-Hydroxyprogesterone Caproate Use
por: Ransom, Carla E., et al.
Publicado: (2011)

An unusual cause of adrenal insufficiency with elevation of 17-hydroxyprogesterone: case report
por: Teti, Claudia, et al.
Publicado: (2023)

A Case of Salt-Wasting 21-Hydroxylase Deficiency With Resistance to Aldosterone due to Urinary Tract Infection
por: Shimakawa, Urara, et al.
Publicado: (2020)

24-Hour Profiles of 11-Oxygenated C(19) Steroids and Δ(5)-Steroid Sulfates during Oral and Continuous Subcutaneous Glucocorticoids in 21-Hydroxylase Deficiency
por: Turcu, Adina F., et al.
Publicado: (2021)

Functional effects of 17alpha-hydroxyprogesterone caproate (17P) on human myometrial contractility in vitro
por: Sexton, Donal J, et al.
Publicado: (2004)

THU207 11-oxygenated Androgens Are Strongly Associated With Treatment Quality In Children With Congenital Adrenal Hyperplasia Due To 21-Hydroxylase Deficiency
por: Abawi, Ozair, et al.
Publicado: (2023)

Comparison of oral Dydrogesterone and 17-α hydroxyprogesterone caprate in the prevention of preterm birth
por: Alizadeh, Fahimeh, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2mubdblciphjpo8etbnlm1uhpt